Thrive Capital Management (Pennsylvania)’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,085
Closed -$428K 111
2021
Q3
$428K Sell
1,085
-70
-6% -$32.2K 0.32% 81
2021
Q2
$532K Buy
1,155
+411
+55% +$166K 0.41% 69
2021
Q1
$278K Buy
+744
New +$303K 0.26% 95

Other funds holding ILMN

Thrive Capital Management (Pennsylvania)'s ILMN Position: Q4 2021 in Review

Thrive Capital Management (Pennsylvania) sold out of Illumina (ILMN) in Q4 2021, closing a stake of 1,085 shares — an estimated $428K sold.

Thrive Capital Management (Pennsylvania) first reported a position in ILMN in Q1 2021 and held it in 3 quarters. The position peaked at $532K in Q2 2021. 1,066 funds tracked by Wall St. Rank hold ILMN as of Q4 2021.

  • Thrive Capital Management (Pennsylvania) reported no remaining Illumina position as of Q4 2021 after selling out during the quarter.
  • Thrive Capital Management (Pennsylvania) sold 1,085 Illumina shares in Q4 2021, an estimated $428K.
  • Thrive Capital Management (Pennsylvania) first reported a position in Illumina in Q1 2021 and held it in 3 quarters.
  • Thrive Capital Management (Pennsylvania)'s Illumina position peaked at $532K in Q2 2021.
  • 1,066 funds tracked by Wall St. Rank held Illumina as of Q4 2021.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q4 2021, filed 9 Feb 2022.